General Surgery Devices are used in diagnostic and surgical interventions primarily for the gastrointestinal tract, abdomen, and pelvis. Robotic Surgical Systems are designed to work around the limitations still present in Minimally Invasive Surgical (MIS) interventions by improving surgeon’s accuracy and facilitating difficult interventions. GlobalData uses proprietary data and analytics to provide a comprehensive report on the robotic surgical systems market in France. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the robotic surgical systems market in France was Intuitive Surgical followed by Stryker, Auris Health, Zimmer Biomet Robotics, Mazor Robotics, Blue Belt Technologies, Globus Medical and Depuy Synthes.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Robotic Surgical Systems are passive devices controlled by a surgeon, and typically consist of a patient side cart, a surgeon console, and a vision system. These Robotic Surgical Systems exist for an array of indications, from all-purpose systems indicated for a variety of general surgery interventions to specialized systems. Both general and specialized systems are considered under Robotic Surgical Systems. Orthopedic Robotic Surgical Systems are specialized to improve surgical outcomes for indications that cover orthopedic surgeries. General Surgery Robotic Surgical Systems are specialized to cover various indications. Neurosurgery Robotic Surgical Systems are specialized to perform complex surgeries which are comparatively more sensitive.
The robotic surgical systems market in France can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size robotic surgical systems in France, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
